#SpecializedProresolvingMediators #SPMs

In this interview, Dipak Panigrahy, MD discusses the emerging impact of specialized pro-resolving mediators (SPMs) on tumor size and growth, highlighting his work with several preclinical models including pancreatic cancer and breast cancer. Dr Panigrahy outlines the reduction in metastases seen in preclinical cancer models, including pancreatic cancer, following treatments with various SPMs. Finally, Dr Panigrahy describes results in preclinical models showing that SPM treatment helps to clear tumor debris caused by standard of care cancer treatments.

Visit us today: https://www.metagenicsinstitute.com/

Get Social With Metagenics Institute
Facebook:   / metagenicsinstitute  
Twitter:   / metagenicsinst  
Instagram:   / metagenicsinstitute  
LinkedIn:   / metagenicsinstitute